Vascular Solutions, Inc. (VASC) Given Average Recommendation of “Hold” by Brokerages

Vascular Solutions, Inc. (NASDAQ:VASC) has been given an average recommendation of “Hold” by the seven ratings firms that are covering the stock. Six research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $47.00.

A number of research firms have recently commented on VASC. Zacks Investment Research lowered Vascular Solutions from a “buy” rating to a “hold” rating in a research report on Wednesday, December 28th. Piper Jaffray Companies lowered Vascular Solutions from an “overweight” rating to a “neutral” rating in a research report on Monday, December 5th. Needham & Company LLC lowered Vascular Solutions from a “buy” rating to a “hold” rating in a research report on Friday, December 2nd. Feltl & Co. lowered Vascular Solutions from a “buy” rating to a “hold” rating in a research report on Friday, December 2nd. Finally, Canaccord Genuity lowered Vascular Solutions from a “buy” rating to a “hold” rating in a research report on Monday, December 5th.

Your IP Address:

In other news, VP Chad Kugler sold 1,849 shares of the firm’s stock in a transaction dated Thursday, December 22nd. The stock was sold at an average price of $55.70, for a total transaction of $102,989.30. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 6.90% of the company’s stock.

Several large investors have recently added to or reduced their stakes in VASC. Municipal Employees Retirement System of Michigan raised its stake in Vascular Solutions by 1.6% in the third quarter. Municipal Employees Retirement System of Michigan now owns 3,850 shares of the medical device company’s stock worth $186,000 after buying an additional 60 shares in the last quarter. Campbell Newman Asset Management Inc. acquired a new stake in Vascular Solutions during the third quarter worth approximately $203,000. First Mercantile Trust Co. raised its stake in Vascular Solutions by 129.4% in the third quarter. First Mercantile Trust Co. now owns 4,242 shares of the medical device company’s stock worth $205,000 after buying an additional 2,393 shares in the last quarter. TD Asset Management Inc. acquired a new stake in Vascular Solutions during the third quarter worth approximately $206,000. Finally, Capstone Investment Advisors LLC acquired a new stake in Vascular Solutions during the fourth quarter worth approximately $214,000. 80.18% of the stock is currently owned by institutional investors.

Vascular Solutions (NASDAQ:VASC) remained flat at $56.00 during midday trading on Monday. Vascular Solutions has a 12-month low of $25.06 and a 12-month high of $57.15. The company has a 50 day moving average price of $55.89 and a 200-day moving average price of $51.22.

Vascular Solutions Company Profile

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

5 Day Chart for NASDAQ:VASC

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/vascular-solutions-inc-vasc-given-average-recommendation-of-hold-by-brokerages/1708897.html

Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *